Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'signaling pathways apoptosis pd 1 pd l1 interaction'

Search results for: 'signaling pathways apoptosis pd 1 pd l1 interaction'

Items 1-10 of 1287

Page
per page
  1. PD 173074
    A8253 PD 173074
     5 Citation
    Target: VEGFR|FGFR
    Summary: FGFR inhibitor
      ≥26.18 mg/mL
  2. PD 334581
    B5727 PD 334581
    Summary: MEK1 inhibitor
      <54.53 mg/mL
  3. PD 151746
    B4791 PD 151746
    Target: Calpains
    Summary: calpain inhibitor, cell-permeable
      insoluble in H2O; ≥11.6 mg/mL
  4. PD 180970
    A8606 PD 180970
    Summary: P210bcr/abl tyrosine kinase inhibitor
      <21.46 mg/mL
  5. PD 169316
    A8689 PD 169316
    Target: p38
    Summary: P38 MAPK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.3 mg/mL
  6. PD 176252
    B7122 PD 176252
    Summary: gastrin-releasing peptide receptor (GRP-R, BB2) and neuromedin B receptor (NMB-R, BB1) antagonist
      <58.47 mg/mL
  7. PD 198306
    B7124 PD 198306
    Summary: MEK1/2 inhibitor
      Soluble in DMSO
  8. PD 173212
    B7424 PD 173212
    Summary: N-type voltage-gated calcium channel blocker
      Soluble in DMSO
  9. PD 81723
    B6705 PD 81723
    Summary: Allosteric potentiator at the adenosine A1 receptor
      <29.93 mg/mL
  10. PD 102807
    B6821 PD 102807
    Summary: M4 muscarinic receptor antagonist
      <39.24 mg/mL

Items 1-10 of 1287

Page
per page